RDHL (Redhill Biopharma Ltd.) Stock Analysis - SEC Filings

Redhill Biopharma Ltd. (RDHL) is a publicly traded Healthcare sector company. As of May 21, 2026, RDHL trades at $0.91 with a market cap of $4.85M and a P/E ratio of 0.00. RDHL moved -0.98% today. Year to date, RDHL is -34.36%; over the trailing twelve months it is -51.63%. Its 52-week range spans $0.71 to $9.25. Rallies surfaces RDHL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find RDHL SEC filings?

Rallies organizes RDHL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

RDHL Key Metrics

Key financial metrics for RDHL
MetricValue
Price$0.91
Market Cap$4.85M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$9.25
52-Week Low$0.71
Volume2.19K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest RDHL News

Recent RDHL Insider Trades

  • Raday Gilead sold 15.74M (~$1.57K) on Apr 6, 2026.

RDHL Analyst Consensus

RDHL analyst coverage data. Average price target: $0.00.

Common questions about RDHL

Where can I find RDHL SEC filings?
Rallies organizes RDHL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show RDHL 10-K and 10-Q filings?
Rallies organizes RDHL SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is RDHL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RDHL. It does not provide personalized investment advice.
RDHL

RDHL